Skip to main content
. 2015 Sep 8;6(31):31493–31507. doi: 10.18632/oncotarget.5154

Figure 3. ITGA9 and WNT7A are downregulated in NPC clinical samples.

Figure 3

Expression of ITGA9 A. and WNT7A B. evaluated in NPC tumor cells and adjacent control nasopharyngeal epithelium by immunostaining.